Cancer-free LNs harbour fewer CD4+ T cells, CD8+ T cells [44], CD80+, CD86+ and CD40+ immune cells [47] and DCs which do not show characteristics associated with effective antigen presentation [51]. This evidence concerns the gene CD86 and cancer.